Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Plunges 4%; BSE HEALTHCARE Index Up 0.9%
Mon, 22 Jul 15:32

Jubilant Pharmova Plunges 4%; BSE HEALTHCARE Index Up 0.9%Image source: ThinkNeo/www.istockphoto.com

Jubilant Pharmova share price has plunged 4% and is presently trading at Rs 725.8.

Meanwhile, the BSE HEALTHCARE index is at 38,498.1 (up 0.9%).

Among the top losers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (down 1.7%) and CAPLIN POINT (down 1.5%).

ALEMBIC PHARMA (up 4.1%) and SUVEN PHARMACEUTICALS (up 3.5%) are among the top gainers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 398.2 to Rs 725.8, registering a gain of Rs 327.6 (up 82.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,342.4 to 38,498.1, registering a gain of 46.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 97.1%), Lupin (up 92.8%) and Cadila Healthcare (up 92.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,511.4 (down 0.1%).

The top losers among the BSE Sensex today are Reliance Ind. (down 3.5%) and Kotak Bank (down 3.4%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,515.9 (down 0.1%). Wipro and Reliance Ind. are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,795.1 to 80,511.4, registering a gain of 13,716.3 points (up 20.5%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 6410.8% YoY to Rs 4,818 million for the quarter ended June 2024, compared to a profit of Rs 74 million a year ago. Net sales rose 9.1% to Rs 17,317 million during the period as against Rs 15,869 million in April-June 2023.

For the year ended March 2023, Jubilant Pharmova reported 115.7% decrease in net profit to Rs -649 million compared to net profit of Rs 4,130 million during FY22. Revenue of the company grew 2.5% to Rs 62,817 million during FY23.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 22.1.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Plunges 4%; BSE HEALTHCARE Index Up 0.9%". Click here!